Primary record
Chryseno(2,3-d)(1,3)dioxole-2,7(4ah,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-
- 库存
- 6,283 克
- 纯度
- 99.0 %
- CAS
- 1040085-99-1
化合物标识与属性
- CAS
- 1040085-99-1
- PubChem CID
- 118989637
- SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3(C(=O)[C@@]2(O1)CO)C)O)C
- Canonical SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)C(=O)[C@]2(CO)O1
名称与同义词
- Budesonide Impurity C
- Budesonide EP Impurity C
- 7BYQ3VT7JN
- 16-Hydroxycapsaicin
- D-HOMOBUDESONIDE
- UNII-7BYQ3VT7JN
- Budesonide impurity C [EP]
- 1040085-99-1
- RefChem:197152
- (Mixture of Diastereomers)"
- SCHEMBL30777669
- BUDESONIDE IMPURITY C [EP IMPURITY]
- DA-51469
- FB146157
- BUDESONIDE D-HOMO ANALOG [USP IMPURITY]
- BUDESONIDE IMPURITY C (EP IMPURITY)
- BUDESONIDE D-HOMO ANALOG (USP IMPURITY)
- G14641
- (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-5,6,10a,11,11a,11b,12,13-octahydro-4bH-chryseno[2,3-d][1,3]dioxole-2,7-dione
- 16a,17-[(1RS)-Butylidenebis(oxy)]-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
- 16alpha,17-((1RS)-Butylidenebis(oxy))-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
- Chryseno(2,3-d)(1,3)dioxole-2,7(4ah,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-
- 16.ALPHA.,17-((1RS)-BUTYLIDENEBIS(OXY))-11.BETA.-HYDROXY-17-(HYDROXYMETHYL)-D-HOMOANDROSTA-1,4-DIENE-3,17A-DIONE
- 16alpha,17-[(1RS)-Butylidenebis(oxy)]-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dion
- 16alpha,17-[(1RS)-Butylidenebis(oxy)]-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
- (11b,16a)-16,17-[Butylidenebis(oxy)]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-al
- (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-4b,6,6a,7a,10a,11,11a,11b,12,13-Decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propylchryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione
- (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,5,6,6a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,7aH)-dione
- 16,17-[Butylidenebis(oxy)]-11-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
- 16a,17-[(1RS)-Butylidenebis(oxy)]-11b-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (Mixture of Diastereomers)
- 16alpha,17-[(1RS)-butylidenebis(oxy)]-11beta-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione
- 4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propylflavono[2,3-d] [1,3] oxazole-2,7(4aH, 5H)-dione
- 4b,6,6a,7a,10a,11,11a,11b,12,13-Decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propylchryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-
- Chryseno[2,3-d][1,3]dioxole-2,7(4aH,5H)-dione, 4b,6,6a,7a,10a,11,11a,11b,12,13-decahydro-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-, (4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-